Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
34
Number of overlapping holdings
70.8%
% of CANC's 48 holdings also in IBB
15.2%
% of IBB's 260 holdings also in CANC
Overlap by Weight
Sector Drift (CANC minus IBB)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in IBB |
Overlap | |
|---|---|---|---|---|
 |
AMGEN INC | 2.6% | 8.0% | 2.6% |
 |
ARGENX SE ADR | 1.7% | 3.1% | 1.7% |
|
BEIGENE LTD. SPONSORED ADR | 2.7% | 1.6% | 1.6% |
|
REGENERON PHARMACEUTICALS | 1.3% | 7.3% | 1.3% |
|
EXELIXIS INC | 3.8% | 1.2% | 1.2% |
Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to IBB
|
REVOLUTION MEDICINES, INC. | 5.0% |
 |
ROCHE HOLDINGS LTD-SPONS ADR | 4.9% |
|
ELI LILLY & CO | 4.9% |
 |
ASTRAZENECA PLC | 4.1% |
|
NOVARTIS AG | 4.1% |
|
BRISTOL-MYERS SQUIBB CO | 3.7% |
|
SUMMIT THERAPEUTICS INC | 3.7% |
|
BRIDGEBIO PHARMA, INC. | 3.7% |
|
NUVALENT, INC. CLASS A | 3.5% |
 |
ZAI LAB LTD. UNSPONSORED ADR | 2.7% |
CANC Underweight Relative to IBB
|
VERTEX PHARMACEUTICALS INC | -9.2% |
|
GILEAD SCIENCES INC | -6.8% |
|
REGENERON PHARMACEUTICALS | -6.0% |
|
AMGEN INC | -5.4% |
|
ALNYLAM PHARMACEUTICALS INC | -3.7% |
|
IQVIA HOLDINGS INC | -3.1% |
|
METTLER-TOLEDO INTERNATIONAL | -2.6% |
|
WATERS CORP | -2.4% |
|
NATERA INC | -2.3% |
|
BIOGEN IDEC INC | -2.1% |